Literature DB >> 212736

6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.

R F Pratt, M J Loosemore.   

Abstract

6-beta-Bromopenicillanic acid, which arises from the epimerization of 6-alpha-bromopenicillanic acid in aqueous solution or from hydrogenation of 6,6-dibromopenicillanic acid, is a powerful, irreversible, active-site-directed inhibitor of several typical beta-lactamases (penicillinase; penicillin amido-beta-lactamhydrolase, EC 3.5.2.6); 6-alpha-bromopenicillanic acid, being completely inhibited at less than micromolar concentrations through what is probably a 1:1 interaction. The B. licheniformis exoenzyme is similarly susceptible, while the Staphylococcus aureus enzyme and the Escherichia coli (R factor) enzyme are less so; the B. cereus beta-lactamase II is not inhibited. Very high concentrations (greater than or equal to 0.1 M) of benzylpenicillin, a good substrate, are required to significantly reduce the rate of inhibition of B. cereus beta-lactamase I by 6-beta-bromopenicillanic acid.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212736      PMCID: PMC336068          DOI: 10.1073/pnas.75.9.4145

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Treatment of gonorrhea -- is penicillin passé.

Authors:  W M McCormack
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

Review 2.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

3.  A spectrophotometric assay of beta-lactamase action on penicillins.

Authors:  S G Waley
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

4.  Involvement of a carboxyl group in the active site of Bacillus cereus 569-H penicillinse ( -lactamase I).

Authors:  G V Patil; R A Day
Journal:  Biochim Biophys Acta       Date:  1973-02-15

5.  The amino acid sequence of Staphylococcus aureus penicillinase.

Authors:  R P Ambler
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

6.  The partial amino acid sequence of the extracellular beta-lactamase I of Bacillus cereus 569/H.

Authors:  D R Thatcher
Journal:  Biochem J       Date:  1975-05       Impact factor: 3.857

7.  Bacillus cereus beta-lactamase. Reaction with N-bromosuccinimide and the properties of the product.

Authors:  H Ogawara; H Umezawa
Journal:  Biochim Biophys Acta       Date:  1975-06-24

8.  Preparation of gram quantities of a purified R-factor-mediated penicillinase from Escherichia coli strain W3310.

Authors:  J Melling; G K Scott
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Separation, purification and properties of beta-lactamase I and beta-lactamase II from Bacillus cereus 569/H/9.

Authors:  R B Davies; E P Abraham
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

View more
  23 in total

1.  Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.

Authors:  A K Knap; R F Pratt
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

2.  6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.

Authors:  F De Meester; J M Frère; S G Waley; S J Cartwright; R Virden; F Lindberg
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

3.  [Clinical significance of beta-lactamase inhibitors].

Authors:  D Adam
Journal:  Klin Wochenschr       Date:  1988-01-15

Review 4.  Chemistry of newer antibiotics directed toward overcoming bacterial resistance.

Authors:  L A Mitscher
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 5.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  beta-Lactamase-catalyzed hydrolysis of acyclic depsipeptides and acyl transfer to specific amino acid acceptors.

Authors:  R F Pratt; C P Govardhan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.

Authors:  J M Frère; C Dormans; C Duyckaerts; J De Graeve
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

8.  beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function.

Authors:  G Dalbadie-McFarland; L W Cohen; A D Riggs; C Morin; K Itakura; J H Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 10.  Three decades of the class A beta-lactamase acyl-enzyme.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.